Ketamine and Depression
Depression often manifests through symptoms like waking in the early morning and struggling to envision a positive future. Surprisingly, ketamine, an NMDA receptor antagonist, has shown the ability to extend the fight for survival in animals, suggesting it may alleviate feelings of helplessness. This paradox highlights the complex relationship between neuroplasticity and depression recovery, leading to remarkable clinical outcomes when ketamine is used in treating depressed patients.In this clip
From this podcast
Huberman Lab
Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast
Related Questions
How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Understanding Depression Relief?
How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode "Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast" and the clip "Neural Circuits of Depression"?
How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Understanding Depression Relief?